Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus-Reference-Cited by-同舟云学术

Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus

Published:2017-07-11 Issue:3 Volume:18 Page:431-435
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Prudente S,Di Paola R^ORCID,Pezzilli S,Garofolo M,Lamacchia O,Filardi T,Mannino G C,Mercuri L,Alberico F,Scarale M G,Sesti G,Morano S,Penno G,Cignarelli M,Copetti M,Trischitta V

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201732.pdf

Reference31 articles.

1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197–2223.

2. Whiting DR, Guariguata L, Weil C, Shaw J . IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311–321.

3. Smith RJ, Nathan DM, Arslanian SA, Groop L, Rizza RA, Rotter JI . Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know. J Clin Endocrinol Metab 2010; 95: 1566–1574.

4. Giugliano D, Maiorino MI, Bellastella G, Esposito K . Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59. Diabetes Care 2016; 39: S86–S87.

5. Herman WH, Kalyani RR, Wexler DJ, Matthews DR, Inzucchi SE . Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59. Diabetes Care 2016; 39: S88–S89.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between diabetic and hypertensive drugs: a pharmacogenetics approach;Molecular Genetics and Genomics;2023-05-07

2. Insulin receptor substrate-1 gene polymorphism and lipid panel data in type 2 diabetic patients with comorbid obesity and/or essential hypertension;Endocrine Regulations;2023-01-01

3. Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome;Genes;2022-08-17

4. Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients;Acta Diabetologica;2022-04-28

5. Role of Genetic and Environmental Factors in Determining the Response to Metformin;Diabetes mellitus;2021-10-15